BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 106 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,410,114 | +6.2% | 916,382 | +35.0% | 0.22% | -6.9% |
| Q2 2023 | $17,328,386 | +39.8% | 679,012 | +16.6% | 0.23% | +35.1% |
| Q1 2023 | $12,391,009 | +9.9% | 582,558 | +53.0% | 0.17% | -2.8% |
| Q4 2022 | $11,273,130 | +38.9% | 380,849 | -45.4% | 0.18% | +91.3% |
| Q3 2022 | $8,114,106 | +21.2% | 697,026 | +74.7% | 0.09% | -30.3% |
| Q2 2022 | $6,696,000 | +13.7% | 399,023 | +197.3% | 0.13% | +85.9% |
| Q1 2022 | $5,889,000 | -41.3% | 134,204 | -18.5% | 0.07% | -1.4% |
| Q4 2021 | $10,026,000 | +34.5% | 164,715 | -8.1% | 0.07% | +10.8% |
| Q3 2021 | $7,455,000 | +15.9% | 179,261 | -15.4% | 0.06% | +12.1% |
| Q2 2021 | $6,432,000 | -10.3% | 211,874 | -11.8% | 0.06% | -28.4% |
| Q1 2021 | $7,173,000 | +1081.7% | 240,134 | +609.7% | 0.08% | +1520.0% |
| Q4 2020 | $607,000 | +2.7% | 33,834 | +9.0% | 0.01% | -58.3% |
| Q3 2020 | $591,000 | – | 31,031 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |